Drug-packaging maker Gerresheimer reported a lower core profit for the first half of 2026 on Wednesday, as weakness in its Moulded Glass business and lower demand for injection vials weighed on performance.
German drugs packaging firm Gerresheimer said on Wednesday it was selling two of its packaging units to private equity group Apax Funds for €1.5 billion ($1.71 billion) including debt.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.